Pharma Stocks Outlook for the week - 07 to 11.11.2016
Myriad triggers such as the September quarter earnings, regulatory issues, and US presidential
elections will affect pharmaceutical stocks next week, even as the report of legal authorities in the
US filing charges against generic drug markets continues to spook investors.
Pharmaceutical stocks were the worst hit yesterday and contributed the most to the 0.6% decline in
both S&P BSE Sensex and Nifty 50 today, on news reports that US prosecutors are likely to file
charges against major companies by the end of 2016 for colluding to raise prices of drugs. It believes
the drug pricing probe does not warrant a sharp fall in stock prices. The report may continue to
weigh on stocks of pharma companies for the first half next week, but it will be taken over by the
earnings of Cipla, Lupin, Sun Pharmaceutical Industries, and Wockhardt.
On Thursday, Sun Pharmaceutical Industries will detail its Jul-Sep earnings. On technical charts,
share of the company are likely to find support at Rs. 625, If do fall to the level, it would give
investors a good opportunity to buy the stock.
Next week, Lupin may also be boosted by news that the US Food and Drug Administration has
cleared the company's Goa facility, which will help it resume its exports and start product filings.
While Cipla reported its earnings on Wednesday, Wockhardt will do so on Thursday
Free Intraday Tips : Join Our Whatsapp No : 9841986753
elections will affect pharmaceutical stocks next week, even as the report of legal authorities in the
US filing charges against generic drug markets continues to spook investors.
Pharmaceutical stocks were the worst hit yesterday and contributed the most to the 0.6% decline in
both S&P BSE Sensex and Nifty 50 today, on news reports that US prosecutors are likely to file
charges against major companies by the end of 2016 for colluding to raise prices of drugs. It believes
the drug pricing probe does not warrant a sharp fall in stock prices. The report may continue to
weigh on stocks of pharma companies for the first half next week, but it will be taken over by the
earnings of Cipla, Lupin, Sun Pharmaceutical Industries, and Wockhardt.
On Thursday, Sun Pharmaceutical Industries will detail its Jul-Sep earnings. On technical charts,
share of the company are likely to find support at Rs. 625, If do fall to the level, it would give
investors a good opportunity to buy the stock.
Next week, Lupin may also be boosted by news that the US Food and Drug Administration has
cleared the company's Goa facility, which will help it resume its exports and start product filings.
While Cipla reported its earnings on Wednesday, Wockhardt will do so on Thursday
